Introduction {#S1}
============

Mastitis is the foremost production and major economic burden confronted by the global dairy industry ([@B58]; [@B28]). Bovine clinical mastitis (CM) milk is now considered to host a complex microbial community with great diversity ([@B50]; [@B16]; [@B28]). The most frequently isolated pathogens are *Staphylococcus aureus, Escherichia coli, Klebsiella* spp., *Streptococcus* spp., *Mycoplasma* spp., *Enterobacter* spp., *Bacillus* spp., and *Corynebacterium* species ([@B1]; [@B19]; [@B26]). Therefore, the accurate identification of pathogens that cause CM enables appropriate choices for antimicrobial treatment and preventive mastitis management ([@B56]; [@B69]; [@B5]). Over the past two decades, a wide range of phenotyping and genotyping methods have been implemented to study mastitis-causing bacteria ([@B56]; [@B19]; [@B26]; [@B5]). Although culture-based techniques are traditionally used to detect CM bacteria, these methods are time-consuming and have the inherent drawback of not being applicable to non-cultivable bacteria ([@B3]). Until recently, 16S rRNA partial gene sequencing remained the most commonly used genomic survey tool to study bovine mastitis microbiomes ([@B50]; [@B16]; [@B8]). However, this technique has limitations because of polymerase chain reaction (PCR) bias, lower taxonomic resolution at the species level, and limiting information on gene abundance and functional profiling ([@B51]). Shotgun whole metagenome sequencing (WMS), on the other hand, better characterizes the breadth of microbial diversity in a sample and successfully provides insight into the phylogenetic composition, species and/or strain, and functional diversity for a variety of biomes ([@B62]; [@B51]). This WMS typically produces high complexity datasets with millions of short reads allowing extensive characterization of the microbiome in an ecological niche, profiling its functional attributes, and gradually becoming a cost-effective metagenomic approach ([@B62]; [@B51]; [@B28]).

Currently, antimicrobial treatment is indispensable to keeping bovine udder health, animal welfare, and economic aspects in balance ([@B56]; [@B34]; [@B5]). Therefore, dependence on antimicrobials has become a widespread phenomenon on dairy farms for mastitis management, prevention, and control programs. However, efficacy of antimicrobial therapy against bovine CM pathogens is low ([@B5]), and the use of antibiotics is confined to selected severe CM cases only ([@B58]; [@B5]). The prevalence of antimicrobial resistance (AMR) in bovine CM pathogens has been investigated in numerous studies ([@B56]; [@B34]; [@B5]). The secretion of antimicrobial compounds by microbes is an ancient and effective method to improve the survival of microbes competing for space and nutrients with other microorganisms ([@B11]). The vast diversity of bacterial species in CM milk, many with short generation times and rampant horizontal gene transfer, permit the rapid accumulation of countless resistant variants at a relatively high evolutionary pace ([@B11]; [@B70]). However, resistance in CM bacteria typically goes unnoticed until a given species becomes of clinical interest, and the associated resistome is also suspected to be a source of newly emerging resistance genes in CM pathogens ([@B34]; [@B5]; [@B28]; [@B72]). Bacteria residing in the bovine gastrointestinal tract and udder may become resistant to these antibiotics and, once released into the milk, they may take part in horizontal transfer of antibiotic resistance genes (ARGs) to other CM bacteria of contagious and environmental origin ([@B5]; [@B72]). Furthermore, AMR is a global health concern in both human and veterinary medicine ([@B69]), and thus, monitoring the emergence of AMR strains is an essential component of bovine CM prevention and control strategies ([@B67]; [@B5]). Therefore, finding an effective alternative strategy for the control of bovine mastitis is a challenge for dairy producers.

The antimicrobial properties of metals have been documented throughout the history of medicine and healthcare ([@B68]). Metal salts such as chromium (Cr), cobalt (Co), nickel (Ni), copper (Cu), and zinc (Zn) are effective in controlling bacterial transmission and infection risks ([@B68]). However, their uses are limited due to their toxicity and possible detrimental environmental effects in dairy industries particularly as therapeutic agents against bovine CM pathogens. Biofilm formation (BF) is an important virulence factor for mastitis causing bacteria and contributes to resistance to different classes of antimicrobials ([@B63]). Bacterial pathogens identified in this study showed a broad spectrum of antimicrobial (antibiotics, toxic metals) resistance, and possessed biofilm forming and quorum sensing (QS) abilities, which might be potential factors in hindering CM cures; thereby leading to the persistence of the disease, and the increased risk of transmission to non-infected dairy cows. However, genetic information about resistance or *in vitro* assays of resistance is not enough to understand the resistome when considered in isolation rather than in combination ([@B69]; [@B3]). Here we describe the resistance potentials in the CM microbiome of four major cattle breeds (Local Zebu, LZ; Red Chattogram Cattle, RCC; Sahiwal, SW; Crossbred Holstein Friesian; XHF) of Bangladesh using both metagenomic deep sequencing (WMS) and *in vitro* cultural approaches. We aim to investigate the influences of metabolic genomic potentials of the microbiomes in predicting and understanding the role of resistant potentials in the pathophysiology of bovine CM. We also test if cattle breeds or host genetics influence the milk microbiota composition and susceptibility to disease and resistance to bacterial infection ([@B8]; [@B9]; [@B22]).

Materials and Methods {#S2}
=====================

Ethics Statement {#S2.SS1}
----------------

The protocol for milk sample collection from lactating dairy cows was approved by the Animal Experimentation Ethical Review Committee (AEERC), Faculty of Biological Sciences, University of Dhaka under reference number 79/Bio. Scs., dated: 12-12-2019.

Screening for Clinical Mastitis and Sampling {#S2.SS2}
--------------------------------------------

We screened 260 udder quarter milk samples collected from 260 CM affected cows belonging to 50 smallholding dairy farms in two geographical regions of Bangladesh (central region, CR = 160; southeastern region, SER = 100) ([Supplementary Figure S1](#FS3){ref-type="supplementary-material"}). The cows represented four different breeds, including local zebu (LZ), red Chattogram cattle (RCC), Sahiwal (SW), and crossbred Holstein Friesian (XHF) at their early stage of lactation (within 10--40 days post-calving). A screening test for CM was conducted using the California Mastitis Test (CMT^®^, Original Schalm reagent, ThechniVet, United States) ([@B27]). Approximately 15--20 mL of milk from each cow was collected under aseptic conditions in a sterile falcon tube during morning milking (8.00--10.00 am) and kept on ice (at 4°C) for transport to the laboratory for subsequent processing.

Metagenomic DNA Extraction and Sequencing {#S2.SS3}
-----------------------------------------

Genomic DNA (gDNA) from 25 randomly selected CM samples was extracted by an automated Maxwell 16 DNA extraction platform using blood DNA purification kits (Promega, United Kingdom) following previously described protocols ([@B28]). DNA quantity and purity were determined with NanoDrop (ThermoFisher, United States) by measuring 260/280 absorbance ratios. Sequencing libraries were prepared with the Nextera XT DNA Library Preparation Kit ([@B23]) and paired-end (2 × 150 bp) sequencing was performed on a NextSeq 500 machine (Illumina Inc., United States) at the George Washington University Genomics Core facility. Our metagenomic DNA yielded a total of 596.74 million reads with an average of 23.87 million (maximum = 39.75 million, minimum = 8.89 million) reads per sample ([Supplementary Material](#FS1){ref-type="supplementary-material"}) before cleaning.

Sequence Reads Preprocessing {#S2.SS4}
----------------------------

The resulting FASTQ files were concatenated and filtered through BBDuk ([@B28]) (with options *k* = 21, mink = 6, ktrim = r, ftm = 5, qtrim = rl, trimq = 20, minlen = 30, overwrite = true) to remove Illumina adapters, known Illumina artifacts, and phiX before bioinformatics analyses. Any sequence below these thresholds or reads containing more than one "N" were discarded. On average, 21.13 million reads per sample (maximum = 36.89 million, minimum = 4.71 million) passed the quality control step ([Supplementary Material](#FS1){ref-type="supplementary-material"}).

Microbiome Diversity and Community Analysis {#S2.SS5}
-------------------------------------------

The shotgun WMS data were analyzed using both mapping-based and assembly-based hybrid methods of PathoScope 2.0 (PS) ([@B25]) and MG-RAST (MR) ([@B20]), respectively. In PS analysis, a "target" genome library was constructed containing all bacterial sequences from the NCBI Database using the PathoLib module ([@B25]). The reads were then aligned against the target libraries using the very-sensitive Bowtie 2 algorithm ([@B37]) and filtered to remove the reads aligned with the cattle genome (bosTau8) and human genome (hg38) as implemented in PathoMap (-very-sensitive-local -k 100--score-min L,20,1.0). Finally, the PathoID ([@B18]) module was applied to obtain accurate read counts for downstream analysis. In these samples, 17.20 million reads (4.3% of total reads) mapped to the target reference genome libraries after filtering for the cow and human genome ([Supplementary Material](#FS1){ref-type="supplementary-material"}). The raw sequences were simultaneously uploaded to the MR server (release 4.0), with proper embedded metadata, and were subjected to the quality filter containing dereplication and removal of host DNA by screening for taxonomic and functional assignment. Alpha diversity (diversity within samples) was estimated using the observed species, Chao1, ACE, Shannon, Simpson and Fisher diversity indices ([@B33]) for both PS and MR read assignments and counts. To visualize differences in bacterial diversity, a principal coordinate analysis (PCoA) was performed based on weighted-UniFrac distances (for PS data) through the Phyloseq R package, version 3.5.1 ([@B46]) and Bray-Curtis dissimilarity matrix ([@B4]) (for MR data). We also used OmicCircos, version 3.9 ([@B29]), an R package based on python scripts, for circular visualization of both microbiome diversity and resistance to antibiotics and toxic compounds (RATC) functional groups found in MR data for our four targeted breeds of CM cows.

*In vitro* Identification of Bacteria {#S2.SS6}
-------------------------------------

Collected CM milk samples (*n* = 260) were subjected to selective isolation and identification of *S. aureus*, *E. coli*, *Klebsiella*, *Enterobacter*, *Shigella*, and *Bacillus* species according to previously described microbiological methods ([@B58]; [@B19]; [@B26]; [@B5]). The pathogens were identified based on their colony morphology, hemolytic patterns on blood agar and Gram-staining ([@B5]). Gram-positive bacteria were further confirmed based on their biochemical characteristics in indole, methyl red, Voges-Proskauer (VP), catalase, oxidase, urease and triple sugar iron (TSI) tests, and growth on mannitol salt agar. Gram-negative bacteria were confirmed based on the results of indole, methyl red, citrate (IMViC) tests and lactose fermentation on MacConkey agar ([@B56]; [@B21]). Finally, all isolates were stored at −80°C for further genomic identification.

PCR Amplification and Ribosomal (16S rRNA) Gene Sequencing {#S2.SS7}
----------------------------------------------------------

Genomic DNA of probable *S. aureus*, *E. coli*, *Klebsiella*, *Enterobacter*, *Shigella*, and *Bacillus* species was extracted from overnight cultures using the boiled method [@B57]). The quantity and purity of the extracted DNA was determined as mentioned before. The 16S rRNA gene was amplified using universal primers 27F (5′-AGAGTTTGATCCTGGCTCAG-3′) and U1492R (5′-CTACGGCTACCTTGTTACGA-3′) ([@B44]). Agarose gel electrophoresis (1.2% wt/vol) was used to verify the presence of PCR products. DNA sequencing was carried out at First Base Laboratories Sdn Bhd (Malaysia) using Applied Biosystems highest capacity-based genetic analyzer (ABI PRISM^®^ 377 DNA Sequencer) platforms with the BigDye^®^ Terminator v3.1 cycle sequencing kit chemistry.

Phylogenetic Analysis of the Microbial Communities {#S2.SS8}
--------------------------------------------------

Taxonomic abundance of the WMS data was determined by applying the "Best Hit Classification" option in the PS pipeline using the NCBI database as a reference, with the following settings: maximum e-value of 1 × 10^--30^, minimum identity of 95% for bacteria, and a minimum alignment length of 20 as the set parameters ([@B44]). A midpoint rooted phylogenetic tree consisting of the top 200 abundant bacterial strains, identified through PS analysis from the WMS reads of the 25 CM samples with \>90% taxonomic identity, was constructed using the maximum-likelihood method in Clustal W, version 2.1 ([@B39]) and visualized using the interactive Tree Of Life (iTOL) ([@B40]). Another phylogenetic tree, which was constructed using the same approach, focused on 40 strains corresponding to the six *in vitro* examined CM bacteria found in 260 CM samples with \>90% taxonomic identity. Using Molecular Evolutionary Genetics Analysis (MEGA) version 7.0 for the larger datasets ([@B35]), the 16S rRNA gene sequences, amplified from all individual bacterial isolates, were aligned with each other and with relevant reference sequences obtained from the NCBI Database using MEGA 7.0, and a maximum-likelihood tree was generated using these 16S rRNA gene sequences with the Tamura-Nei evolutionary model ([@B35]). Nodal confidence in the resulting phylogenetic relationships was assessed using the bootstrap test (1000 replicates) ([@B53]).

Antimicrobial Susceptibility Testing {#S2.SS9}
------------------------------------

The *in vitro* antibiogram profile of 221 CM isolates was determined using the disk diffusion method ([Supplementary Figure S2](#FS3){ref-type="supplementary-material"}) following the Clinical Laboratory Standards Institute ([@B7]) guidelines. Antibiotics were selected for susceptibility testing corresponding to a panel of antimicrobial agents (Oxoid^TM^, Thermo Scientific, United Kingdom) of interest to the dairy industry and public health in Bangladesh. The selected groups of antibiotics were commonly used in treating CM by the dairy farmers and included penicillins (ampicillin, 10 μg/mL), tetracyclines (doxycycline, 30 μg/mL; tetracycline, 30 μg/mL), nitrofurans (nitrofurantoin, 300 μg/mL), quinolones (ciprofloxacin, 10 μg/mL; nalidixic acid, 30 μg/mL), cephalosporins (cefoxitin, 30 μg/mL), penems (imipenem, 10 μg/mL), phenols (chloramphenicol, 30 μg/mL), aminoglycosides (gentamycin, 10 μg/mL; vancomycin, 30 μg/mL), and macrolides (erythromycin, 15 μg/mL). Resistance was defined according to the clinical and laboratory standards institute ([@B7]) with slight modifications ([@B56]; [@B5]).

Metal Susceptibility Testing {#S2.SS10}
----------------------------

The antibacterial effect of heavy metals was evaluated *in vitro* for the isolated pathogens using the agar well diffusion method ([Supplementary Figure S3](#FS3){ref-type="supplementary-material"}) ([@B58]; [@B68]). Five heavy metals such as copper (Cu), zinc (Zn), chromium (Cr), nickel (Ni), and cobalt (Co) were used as salts: CuSO~4~⋅5H~2~O, ZnSO~4~⋅7H~2~O, K~2~Cr~2~O~7~, NiCl~2~, and CoCl~2~⋅6H~2~O, respectively, to study the level of zone of inhibition (ZOI). Briefly, pure culture of the isolated pathogens from NA plates were sub-cultured into Mueller-Hinton agar (Oxoid^TM^, United Kingdom) plates, and respective agar was poured into sterile Petri dishes, which were then cooled. A total of 100 μl of cell suspension was pipetted and spread across the entire area of the agar using a sterile cotton swab. Two to five equal wells (7 mm diameter) were cut out of each agar plate using a sterile cork borer and stainless-steel needle. Varying concentrations of the metal solutions were prepared (2, 4, 8, 16, 32, 48, and 64 μg/mL) and 100 μl of the prepared metal ion solution was added to each of the wells. The plates were incubated at 37°C for 24 h to allow diffusion of the metal into the agar, and the antibacterial activity was determined by measuring the diameter of ZOI in mm ([@B8]). After investigating the resistance profile of the isolates at different concentrations, the minimal inhibitory concentration (MIC) of the metals was determined using the tube dilution method, by gradually increasing or decreasing the heavy metal concentrations ([@B58]). Finally, growth of bacterial colonies was observed and the concentration that showed no growth was considered as the minimum bactericidal concentration (MBC) ([@B58]).

Biofilm Assay and Microscopy {#S2.SS11}
----------------------------

Microtiter plate assays were performed to screen for the BF ability of 80 randomly selected isolates using standard protocols ([@B61]; [@B63]; [@B68]). We quantified the absorbance of solubilized crystal violet (CV), in a plate reader at 600 nm using 30% acetic acid in water as the blank and TSB as the negative control. The solution was removed, and the absorbance measured at optical density-590 (OD590) (*n* = 3). To determine the BF ability of strains, cut-off optical density (ODc) was defined as three standard deviations above the mean OD of the negative control. Strains were classified as: non-biofilm formers, NBF (OD ≤ ODc); weak biofilm formers, WBF (ODc \< OD ≤ 2 × ODc); moderate biofilm formers, MBF (2 × ODc \< OD ≤ 4 × ODc), and strong biofilm formers, SBF (OD \> 4 × ODc) ([@B66]; [@B68]). In this study, the ODc value was set as 0.045 and the mean OD of the negative control was 0.039 ± 0.002 ([@B68]). The biofilm surfaces were then visualized using 5% TSB as nutrient rich media and FilmTracer^TM^ LIVE/DEAD^®^ Biofilm Viability Kit as staining materials to observe the proportion of live or active cells (fluorescent green) under Olympus BX51 upright microscope (40× objective), and finally, images were collected using an Olympus DP73 camera through cellSens entry software (Olympus Corporation, Japan) and visualized using image J software ([@B61]). As a negative control, we used *E. coli* DH5 alpha for all the *in vitro* resistome (antimicrobial and metal susceptibility tests and biofilm assays) analysis tests.

Microbial Functional Analysis {#S2.SS12}
-----------------------------

Metagenomic functional composition was based on the gene families from different levels of the SEED module and the Kyoto Encyclopedia of Genes and Genomes (KEGG) database ([@B32]), using the MR pipeline ([@B20]). We observed significant differences (Kruskal--Wallis test, *P* = 0.001) in the relative abundance of genes coding for RATC and microbial functional genomic potentials in four cattle breeds.

Statistical Analyses {#S2.SS13}
--------------------

The characteristics of the cow breeds with CM were compared using a non--parametric Kruskal--Wallis test for quantitative variables ([@B8]). The Shapiro-Wilk test was used to check normality of the data, and the non--parametric Kruskal--Wallis rank sum test was used to evaluate differences in the relative abundance of bacterial taxa at the strain level according to breed groups ([@B8]; [@B9]; [@B22]). The statistical analyses for the MR data were initially performed by embedded calls to statistical tests in the pipeline and validated further using IBM SPSS (SPSS, Version 23.0, IBM Corp., NY, United States) using the above-mentioned tests. For the functional abundance profiling, the statistical (Kruskal--Wallis test and Pearson correlation) tests were applied at different KEGG and SEED subsystem levels in MR pipeline generated data ([@B20]). To evaluate the significant relationships between identified bacterial species and the study region, we used the two-sample proportions test using SPSS. Results were considered statistically significant when *P* \< 0.05 and highly significant when *P* \< 0.01. Mean values were used to compare the antimicrobial efficacy results of the tested antibiotics and heavy metals at varying concentrations. Standard error means were calculated to analyze the distribution of the data from the mean value, and confidence intervals of 95% were calculated for the MIC and MBC tests results to plot error bars ([@B61]; [@B68]). We also performed Pearson correlation tests to assess the relationships between the taxonomic abundance of the pathogens and AMR, both for cultural and metagenomic data. A *post hoc* Bonferroni test was used to compare the biofilm OD600 mean values ([@B61]; [@B68]).

Results {#S3}
=======

To decipher the resistance potentials in bovine CM microbiomes, we used both *in silico* (WMS, 16S rRNA gene sequencing) and *in vitro* (culture base) approaches. The present WMS investigation leads to the direct and comprehensive evaluation of resistance to antibiotics and toxic compounds (RATC), BF and QS genes in 25 CM milk samples. Furthermore, *in vitro* AMR profiling of six CM causing bacteria (*S. aureus*, *E. coli*, *Klebsiella*, *Enterobacter*, *Bacillus*, and *Shigella*) isolated from 260 CM milk samples was carried out using 12 commonly used antibiotics (ampicillin, doxycycline, tetracycline, nitrofurantoin, ciprofloxacin, nalidixic acid, cefoxitin, imipenem, chloramphenicol, gentamycin, erythromycin, and vancomycin), and five toxic metals (copper, zinc, chromium, nickel, and cobalt). Moreover, we also demonstrated some functional metabolic potentials of CM microbiomes found to be associated with mammary gland pathogenesis.

Sequence Analysis {#S3.SS1}
-----------------

The WMS of 25 CM milk samples generated approximately 600 million reads, ranging from 8.86 to 39.75 million per sample. An average of 21.13 million reads per sample (maximum = 36.89 million, minimum = 4.71 million) passed the quality control step ([Supplementary Material](#FS1){ref-type="supplementary-material"}). We analyzed the sequencing reads simultaneously using two bioinformatics pipelines, PathoScope 2.0 (PS) and MG-RAST (MR).

Microbiome Diversity and Composition in CM {#S3.SS2}
------------------------------------------

We investigated the strain-level microbial community and relative abundances in 25 CM milk samples \[previously published 14 samples ([@B28]) and 11 new samples\] through WMS. The reads generated from WMS were mapped to 391 genera and 519 strains of bacteria through MR and PS analyses, respectively ([Supplementary Material](#FS1){ref-type="supplementary-material"}). The rarefaction curves based on observed species richness reached a plateau after, on average, 23.87 million reads ([Figure 1A](#F1){ref-type="fig"} and [Supplementary Material](#FS1){ref-type="supplementary-material"}), suggesting that the depth of coverage for most samples was sufficient to capture the entire microbial diversity within each sample. We did not, however, find any significant differences in the alpha (observed species, Chao1, ACE, Shannon, Simpson and Fisher diversity estimates) and beta (based on Bray-Curtis dissimilarity matrix) diversities among the microbial communities across the 25 CM samples ([Figures 1B,C](#F1){ref-type="fig"}, respectively). However, significant diversity (alpha and beta) differences were observed among the CM microbiome communities across the four cattle breeds (LZ, RCC, SW, XHF) regardless of the method (i.e., either PS or MR) used to tabulate microbial abundances (PS; *P* = 0.005, MR; *P* = 0.001, Kruskal--Wallis test). In addition, this breed's specific diversity difference remained evident in the microbial ecosystem of XHF cows associated CM milk samples ([Figures 1D,E](#F1){ref-type="fig"}, respectively). The PCoA analysis also showed significant microbial disparity (*P* = 0.001) among the microbiome of four dairy breeds ([Figure 1E](#F1){ref-type="fig"}).

![Bovine clinical mastitis (CM) milk microbiome diversity. **(A)** Rarefaction curves showing the influence of sequencing depth (number of reads per sample, *x*-axis) on species richness (*y*-axis) in CM milk samples. The rarefaction curves representing the number of species per sample indicated that the sequencing depth was sufficient enough to fully capture the microbial diversity as existed. **(B)** Alpha diversity measured using the observed species, Chao 1, ACE and Shannon diversity indices through PathoScope (PS) analysis. The observed species richness (*P*~Observed~ = 0.511), Chao1 (*P*~Chao1~ = 0.081), ACE (*P*~ACE~ = 0.121), Shannon (*P*~Shannon~ = 0.401), Simpson (*P*~Simpson~ = 0.011) and Fisher (*P*~Fisher~ = 0.014) diversity analyses revealed that microbiome diversity did not vary among the CM samples. **(C)** Beta diversity (Principal coordinate analysis; PCoA) measured on the Bray-Curtis distance method using MG-RAST tool for CM causing microbial communities (genus-level) shows that most of the CM samples clustered together (black circle), indicating no significant diversity differences. **(D)** Alpha diversity measured using species richness (*P*~Observed~ = 0.011), Chao1 (*P*~Chao1~ = 0.001), ACE (*P*~ACE~ = 0.021), Shannon (*P*~Shannon~ = 0.001), Simpson (*P*~Simpson~ = 0.009) and Fisher (*P*~Fisher~ = 0.023) diversity matrices on PS data showed significant differences (Kruskal--Wallis test, *P* = 0.002) in microbial diversity across the four cow breeds (Local Zebu cows, LZ; Red Chattogram cows, RCC; Sahiwal, SW; Holstein Friesian cross, XHF). **(E)** PCoA plot based on weighted-UniFrac distance method at strain-level microbiome signature of four breeds of cows reveals that the CM samples appear more distantly (red circles) indicating significant group differences (*P* = 0.001). These differences in the microbiome signature associated with CM across the four breeds could be explained by a large percentage of variation in the first (62.6%) and second (19.7%) axes.](fmicb-11-00860-g001){#F1}

The predominant bacterial phyla we found associated with CM were Proteobacteria, Bacteroidetes, Firmicutes, Actinobacteria, and Fusobacteria (contributing to \>95.0% of the total sequences, Kruskal--Wallis test, *P* = 0.001) in the MR analysis. The strain-level signature of the microbiome demonstrated that most of the species identified in each CM sample were represented by multiple strains ([Supplementary Material](#FS1){ref-type="supplementary-material"}), and of the detected bacterial strains, we identified the top 200 strains according to their relative abundance ([Figure 2](#F2){ref-type="fig"}). The CM associated microbiome was dominated by 29 different strains of *Pseudomonas*, while *Acinetobacter*, *Streptococcus*, *Lactobacillus*, *Corynebacterium*, *Staphylococcus*, and *Enterococcus* were represented by 27, 27, 18, 17, 15, and 10 different strains, respectively ([Figure 2](#F2){ref-type="fig"} and [Supplementary Material](#FS1){ref-type="supplementary-material"}). Thus, among the identified bacterial strains, *A. johnsonii* XBB1 had the highest relative abundance (38.9%) followed by *Micromonospora* sp. HK10 (17.6%). Other bacterial strains with high relative abundance were *Campylobacter mucosalis* (8.7%), *P. putida* KT2440 (7.7%), *Anaerobutyricum hallii* DSM 3353 (6.3%), *P. fragi* (3.2%), *Catenibacterium mitsuokai* DSM 15897 (3.0%), *E. coli* O104:H4 str. 2011C-3493 (2.0%), *A. veronii* (1.2%), *Pantoea dispersa* EGD-AAK13 (1.1%), *P. fluorescens* Pf0-1 (0.8%), *K. oxytoca* (0.7%), and *P. entomophila* L48 (0.5%). The remaining strains had a relatively lower abundance (\<0.5%) ([Supplementary Material](#FS1){ref-type="supplementary-material"}). According to the cattle breeds, the XHF cows had the highest number of microbial strains (*n* = 403) followed by LZ cows (*n* = 230), and SW cows (*n* = 134) and RCC (*n* = 125) ([Figures 3A--C](#F3){ref-type="fig"}, and [Supplementary Material](#FS1){ref-type="supplementary-material"}). The breed specific association revealed that 45.7, 22.6, and 19.1% of the detected bacterial strains in CM milk samples of LZ, SW, and RCC cows, respectively, were also found in the CM microbiome of XHF cows ([Figure 3D](#F3){ref-type="fig"} and [Supplementary Material](#FS1){ref-type="supplementary-material"}).

![The strain-level taxonomic profile of microbiota associated with bovine clinical mastitis (CM). Taxonomic dendrogram showing the top bacterial microbiome of bovine CM milk. Color ranges identify different strains within the tree. Taxonomic dendrogram in the midpoint rooted phylogenetic tree was generated with the top 200 abundant unique strains of bacteria in CM milk metagenome based on the maximum likelihood method in Clustal W and displayed with iTOL (interactive Tree Of Life). Each node represents a single strain shared among more than 50% of the samples at a relative abundance of \>0.0006% of the total bacterial community. Strains and/or species are color-coded by different order of bacteria present in \>80% of samples. The strains in the phylogenetic tree are also available in [Supplementary Material](#FS1){ref-type="supplementary-material"}.](fmicb-11-00860-g002){#F2}

![Strain-level bovine CM microbiome diversity in four different breeds (Local Zebu, LZ; Red Chattogram Cattle, RCC; Sahiwal, SW; Crossbred Holstein Friesian, XHF) of cows through PathoScope analysis. **(A)** Venn diagrams representing the core unique and shared microbiomes of bovine clinical mastitis (CM) in XHF and LZ breeds while **(B)** and **(C)** Venn diagrams showing the unique and shared bacterial strains in XHF and SW and XHF and RCC breeds, respectively. Microbiome sharing between the conditions are indicated by yellow color. **(D)** The circular plot illustrates the relative abundance of the top 75 CM causing bacterial strains in CM milk samples obtained from XHF, LZ, SW, and RCC dairy breeds. Taxa in the respective breed of cows are represented by different colored ribbons, and the inner blue bars indicate their respective relative abundances. The XHF cows had the highest number of microbial strains followed by LZ, SW, and RCC. This breed specific association revealed that 45.66, 22.58, and 19.11% of the detected bacterial strains in CM milk collected from LZ, SW, and RCC cows, respectively, were also seen in the CM milk microbiome of XHF cows. The relative abundance bacterial strains in four breeds is also available in [Supplementary Material](#FS1){ref-type="supplementary-material"}.](fmicb-11-00860-g003){#F3}

Simultaneously, through *in vitro* cultural analysis, a total of 452 isolates that belonged to six bacterial (*S. aureus*, *E. coli*, *Klebsiella*, *Enterobacter*, *Bacillus*, and *Shigella*) species were identified in 260 CM samples (including 25 WMS CM samples) collected from central (CR = 160) and southeastern (SER = 100) regions of Bangladesh ([Supplementary Figure S1](#FS1){ref-type="supplementary-material"}). The overall prevalence of *S. aureus*, *E. coli*, *Klebsiella*, *Enterobacter*, *Bacillus*, and *Shigella* species were 23.5, 18.5, 19.2, 12.3, 9.2, and 17.3% in CM samples, respectively ([Supplementary Table S1](#FS2){ref-type="supplementary-material"}). We found significant differences in the prevalence of these species (*P* = 0.01) when analyzing the distribution of these pathogens according to the origin of the samples (SER and CR) ([Supplementary Figure S4](#FS3){ref-type="supplementary-material"}). The culture-based findings of the current study identified *S. aureus* as the chief etiology of bovine CM in Bangladesh, while *Shigella* species remained the least frequently detected CM pathogen---which corroborates the results of WMS-based taxonomic identification ([Supplementary Figure S5](#FS3){ref-type="supplementary-material"}).

Resistome Composition of CM Associated Microbiome {#S3.SS3}
-------------------------------------------------

For analyses of the resistome composition in CM microbiomes, the SEED module of the MR pipeline provided a comprehensive picture. Using SEED, 147,040 reads aligned to 30 resistance to antibiotics and toxic compounds (RATC), and 10 BF and quorum sensing (BF-QS) functional groups across the CM samples, with different abundances ([Supplementary Material](#FS1){ref-type="supplementary-material"}). The RATC genes were classified into two unique groups, 19 antibiotic resistance and 11 toxic metal resistance groups ([Figure 4](#F4){ref-type="fig"} and [Supplementary Material](#FS1){ref-type="supplementary-material"}). This WMS analysis showed a significant association (Pearson correlation, *P* = 0.001; Non-parametric Spearman's Correlation, *P* = 0.003) between the number of reads aligned to bacterial genomes and the number of reads mapped to RATC genes ([Supplementary Material](#FS1){ref-type="supplementary-material"}). Among the RATC functional groups, multidrug resistance to efflux pumps (MREP, 28.6%), *Cme*ABC operon (8.9%), resistance to fluoroquinolones (RFL, 6.2%), *mdt*ABCD cluster (5.5%), methicillin resistance in *Staphylococci* (MRS, 3.8%), *Bla*R1 regulatory family (*Bla*R1, 3.4%), *Mex*E-*Mex*F-*Opr*N (2.4%), and beta-lactamase resistance (BLAC, 2.2%) were the dominating antibiotic resistance genes (ARGs) found in CM milk microbiomes ([Figure 4A](#F4){ref-type="fig"} and [Supplementary Material](#FS1){ref-type="supplementary-material"}). In addition to ARGs, the WMS analysis also detected a number of metal and toxic metals resistant genes in CM microbiomes. Among them, cobalt-zinc-cadmium resistance (CZCR, 19.3%), copper homeostasis (CH, 9.6%), arsenic resistance (AR, 2.9%), copper homeostasis: copper tolerance (CHCT, 2.3%), and resistance to chromium compounds (RCHC, 1.4%) were the predominate resistant genes ([Figure 4A](#F4){ref-type="fig"} and [Supplementary Material](#FS1){ref-type="supplementary-material"}). Although the relative abundance of these RATC genes varied among the microbiomes of the four breeds (LZ, RCC, SW, and XHF), their resistome composition did not vary significantly (*P* = 0.692) by taxonomic diversity of respective breeds ([Figure 4B](#F4){ref-type="fig"} and [Supplementary Material](#FS1){ref-type="supplementary-material"}).

![Projection of the resistance to antibiotic and toxic compounds (RATC) genes in bovine clinical mastitis (CM) pathogens. **(A)** Heatmap showing the hierarchical clustering of 30 different RATC genes detected in CM associated microbiomes of 25 CM milk samples as measured at level-3 of SEED subsystems in MG-RAST pipeline. The relative abundance of these genes significantly correlated (Pearson correlation, *P* = 0.002) with the relative abundance of the bacterial taxa found in these samples. The color bar at the bottom represents the relative abundance of putative genes and expressed as a value between --1 (low abundance) and 1 (high abundance). The yellow color indicates the more abundant patterns, while blue cells for less abundant RATC gene in that particular sample. The genes coding for MREP (multidrug resistance efflux pumps), CZCR (cobalt-zinc-cadmium resistance), BlaR (BlaR1 family regulatory sensor-transducer disambiguation); BLAC (beta-lactamase resistance), AR (arsenic resistance), RFL (resistance to fluoroquinolones), CH (copper homeostasis), CmeABC Operon (multidrug efflux pump in *Campylobacter jejuni*) had higher relative abundances than other RATC groups found in these CM samples. **(B)** The circular plot illustrates the diversity and relative abundance of the RATC genes detected among the microbiomes of the four different breeds (Local Zebu, LZ; Red Chattogram Cattle, RCC; Sahiwal, SW; Crossbred Holstein Friesian, XHF) of cows through SEED subsystems analysis. We found no significant correlation between the resistome and microbiome diversity in different breeds (*P* = 0.692). The association of the RATC genes according to breeds is shown by different colored ribbons and the relative abundances these genes are represented by inner blue colored bars. Part of the RATC functional groups are shared among microbes of the four breeds (XHF, LZ, SW, and RCC), and some are effectively undetected in the microbiomes of the other breeds. Abbreviations: CH, copper homeostasis; CHCT, copper homeostasis: copper tolerance; RCHC, resistance to chromium compounds; mdtABCD, the mdtABCD multidrug resistance cluster; OprN, mexe-mexf-oprn multidrug efflux system; MROP, mercury resistance to operon; MRS, methicillin resistance in *Staphylococci*; ZR, zinc resistance; BH, bile hydrolysis; ER, erythromycin resistance; ADCYS, adaptation to d-cysteine; SPVTL, *Streptococcus pneumoniae* vancomycin tolerance locus; STR, Streptothricin resistance; MAR Locus, multiple antibiotic resistance to locus; RVAN, resistance to vancomycin; MRD, mercuric reductase; LI, lysozyme inhibitors; AADNYL, aminoglycoside adenylyltransferases; mdtRP, multidrug resistance operon mdtRP of *Bacillus*; FR, Fosfomycin resistance; PSGCB, polymyxin synthetase gene cluster in *Bacillus*; OprM, mexA-mexB-oprm multidrug efflux system; CDR, cadmium resistance. Additional information is also available in [Supplementary Material](#FS1){ref-type="supplementary-material"}.](fmicb-11-00860-g004){#F4}

The resistance potentials of RATC functional groups also varied significantly (*P* = 0.027) in six *in vitro* selected CM pathogens isolated and identified from different sources of CM samples (breed and study areas) under almost the same farming management system ([Figure 5A](#F5){ref-type="fig"} and [Supplementary Material](#FS1){ref-type="supplementary-material"}). Among the RATC groups, the predominant ARGs found were as follows; MRS (*S. aureus*, 37.0%), RFL (*S. aureus*, 14.8%; *Shigella*, 7.8%), MREP (*E. coli*, 28.5%; *Klebsiella*, 28.4%), *Bla*R1 (*E. coli*, 6.0%; *Shigella*, 8.5%), *mdt*ABCD cluster (*E. coli*, 17.5%; *Klebsiella*,18.9%; *Enterobacter*, 21.4%; *Shigella*, 11.7%), multiple antibiotic resistance (MAR) Locus (*E. coli*, 2.4%; *Enterobacter*, 2.6%), *Cme*ABC operon (*E. coli*, 9.1%; *Enterobacter*, 11.0%; *Shigella*, 25.6%), and adaptation to d-cysteine, ADCYS (*Bacillus*, 5.5%) ([Figure 5B](#F5){ref-type="fig"}). Conversely, genes encoding CH in *S. aureus* (11.1%), *E. coli* (4.8%), *Enterobacter* (4.4%), and *Shigella* (6.0%), CHCT in *Klebsiella* (11.2%) and *Shigella* (3.7%), mercuric reductase (MRD) in *S. aureus* (11.1%), mercury resistance to operon (MROP) in *Enterobacter* (2.4%), AR in *S. aureus* (3.7%), *E. coli* (4.4%), *Klebsiella* (10.1%), *Enterobacter* (7.5%) and *Shigella* (7.8%), ZR in *E. coli* (5.6%), cadmium resistance (CDR) in *S. aureus* (3.7%), CZCR in *S. aureus* (3.7%), *E. coli* (10.4%), *Klebsiella* (11.6%), *Enterobacter* (20.3%) and *Shigella* (21.0%), and RCHC in *Bacillus* (85.0%), were the most abundant toxic metals resistant RATC functional groups among the six selected pathogens ([Figure 5C](#F5){ref-type="fig"}). Assessment of the BF-QS ability of the CM microbiomes revealed that autoinducer 2 (AI-2) transport and processing (*lsr*ACDBFGE operon, 33.7%), biofilm adhesion biosynthesis (BAB, 24.2%), protein *Yjg*K cluster linked to BF (*Yjg*K cluster, 15.5%), QS: autoinducer-2 synthesis (QSAU2, 9.4%) were the most abundant genes among CM associated pathogens ([Supplementary Material](#FS1){ref-type="supplementary-material"}). However, by comparing the association of these BF-QS genes among the six selected bacterial pathogens, we found significant variation (*P* = 0.017) in their diversity, composition, and relative abundances ([Figure 5D](#F5){ref-type="fig"} and [Supplementary Material](#FS1){ref-type="supplementary-material"}).

![Heatmap comparison of antibiotics, metals, biofilm formation and quorum sensing genes found in the metagenome sequences (WMS) of six CM causing bacteria through SEED subsystems analysis in MG-RAST pipeline. **(A)** Diversity and relative abundance of the antimicrobial resistance (AMR), metal resistance (MTR), and biofilm formation (BF) and quorum sensing (QS) genes varied significantly (Kruskal--Wallis test, *P* = 0.029) among the study bacteria. **(B)** Relative abundance of AMR genes, **(C)** Relative abundance of MTR genes **(D)** Relative abundance of BF-QS genes. Values are colored in shades of green to yellow to red, indicating low (absent), medium and high abundance, respectively. Abbreviations: MRS, methicillin resistance in *Staphylococci*; RFL, resistance to fluoroquinolones; MREP, multidrug resistance to efflux pumps; BlaR, BlaR1 family regulatory sensor-transducer disambiguation; mdtABCD, the mdtABCD multidrug resistance cluster; MAR Locus, multiple antibiotic resistance; CmeABC Operon, Multidrug efflux pump in *Campylobacter jejuni*; BLAC, beta-lactamase resistance; AADNYL, aminoglycoside adenylyltransferases (Gentamycin resistance); FR, Fosfomycin resistance; mdtRP, multidrug resistance operon mdtRP of *Bacillus*; PSGCB, polymyxin synthetase gene cluster in *Bacillus*; BFS, biofilm formation in *Staphylococcus*, lsrACDBFGE operon, autoinducer 2 (AI-2) transport and processing; QSY, quorum sensing in *Yersinia*; BAB, biofilm adhesion biosynthesis; *Yjg*K cluster, protein *Yjg*K cluster linked to biofilm formation; QSAU2, quorum sensing: autoinducer-2 synthesis; QSRP, quorum sensing regulation in *Pseudomonas*; CH, copper homeostasis; CHCT, copper homeostasis: copper tolerance; MRD, mercuric reductase; MROP, mercury resistance to operon; AR, arsenic resistance; ZR, zinc resistance; CDR, cadmium resistance; CZCR, cobalt-zinc-cadmium resistance; ADCYS, adaptation to d-cysteine; RCHC, resistance to chromium compounds; LI, lysozyme inhibitors; BH, bile hydrolysis. More details about these genes can be found in the text and [Supplementary Material](#FS1){ref-type="supplementary-material"}.](fmicb-11-00860-g005){#F5}

The *in vitro* antibiogram profiling of 221 individual isolates of the six bacteria, revealed that *S. aureus* isolates had the highest resistance to doxycycline, ampicillin, tetracycline, and erythromycin (73.0--88.0%) and moderate resistance to chloramphenicol, ciprofloxacin, and nitrofurantoin (50.0--58.0%) ([Figure 6](#F6){ref-type="fig"} and [Table 1](#T1){ref-type="table"}). The isolates of another Gram-positive bacterium (*Bacillus*) demonstrated the highest resistance against doxycycline, ampicillin, nalidixic acid, and erythromycin (60.0--84.0%). However, *E. coli* isolates exhibited the highest resistance against tetracycline, doxycycline, nalidixic acid, and ampicillin (77.0--93.0%) and moderate resistance to chloramphenicol, nitrofurantoin, gentamicin, and ciprofloxacin (40.0--63.0%). The isolates of *Klebsiella*, *Enterobacter*, and *Shigella* displayed the highest resistance to doxycycline, nalidixic acid, tetracycline, and ampicillin (70.0--100.0%) and moderate resistance to ciprofloxacin, gentamicin, nitrofurantoin, and chloramphenicol (30.0--70.0%). In this study, imipenem and cefoxitin remained as the most sensitive antibiotics against four Gram-negative bacterial (*E. coli*, *Klebsiella*, *Enterobacter*, and *Shigella*) species, while the two Gram-positive (*S. aureus* and *Bacillus*) species were mostly sensitive to imipenem, cefoxitin, and vancomycin ([Figure 6](#F6){ref-type="fig"} and [Table 1](#T1){ref-type="table"}). Taken together, the antibiogram profile revealed that all of the selected CM pathogens are becoming multidrug resistant (MDR, resistant to ≥3 antibiotics) and the highest resistance was found against tetracyclines (tetracycline and doxycycline), followed by quinolones (nalidixic acid), and penicillin (ampicillin) groups of antibiotics ([Figure 6](#F6){ref-type="fig"} and [Table 1](#T1){ref-type="table"}).

![Antibiotic resistance pattern of bovine clinical mastitis pathogens by disk diffusion method. The antimicrobial resistance (AMR) patterns of the six bacteria obtained from 221 CM isolates (*S. aureus*, 56; *E. coli*, 54; *Klebsiella* spp., 42; *Enterobacter* spp., 26; *Bacillus* spp., 31; *Shigella* spp., 12) for twelve commonly used antibiotics from nine different groups/classes. Abbreviations: AMP, Ampicillin; DOX, Doxycycline; TCN, Tetracycline; CIP, Ciprofloxacin; IMP, Imipenem; CHL, Chloramphenicol; GEN, Gentamycin; NAL, Nalidixic acid; NIT, Nitrofurantoin; CFX, Cefoxitin; VAN, Vancomycin; ERY, Erythromycin. More details about AMR profiles can be found in the text and in [Table 1](#T1){ref-type="table"}.](fmicb-11-00860-g006){#F6}

###### 

Antibiotic resistance pattern of bacteria \[*n* (%) of isolates\] associated with bovine clinical mastitis (CM).

  Antibiotic   Content per disk   Breakpoint to declare resistance (≤)   *S. aureus* (*n* = 56)   *E. coli* (*n* = 54)   *Klebsiella* spp. (*n* = 42)   *Enterobacter* spp. (*n* = 26)   *Bacillus* spp. (*n* = 31)   *Shigella* spp. (*n* = 12)
  ------------ ------------------ -------------------------------------- ------------------------ ---------------------- ------------------------------ -------------------------------- ---------------------------- ----------------------------
  AMP          10 μg              28 mm                                  48 (85.71)               42 (77.78)             36 (85.71)                     24 (92.30)                       25 (80.64)                   10 (83.33)
  DOX          30 μg              23 mm                                  49 (87.50)               46 (85.18)             39 (92.86)                     22 (84.61)                       26 (83.87)                   10 (83.33)
  TCN          30 μg              23 mm                                  46 (82.14)               50 (92.59)             38 (90.48)                     24 (92.30)                       11 (35.48)                   12 (100)
  CIP          10 μg              20 mm                                  28 (50.0)                22 (40.74)             18 (42.86)                     8 (30.77)                        13 (41.94)                   4 (33.33)
  IMP          10 μg              22 mm                                  10 (17.86)               12 (22.22)             11 (26.19)                     5 (19.23)                        2 (6.45)                     3 (25.0)
  CHL          30 μg              12 mm                                  32 (57.14)               34 (62.96)             23 (54.76)                     18 (69.23)                       6 (19.35)                    6 (50.00)
  GEN          10 μg              12 mm                                  22 (39.28)               23 (42.60)             21 (50.0)                      4 (15.38)                        23 (74.19)                   5 (41.67)
  NAL          30 μg              16 mm                                  ND                       46 (85.18)             36 (85.71)                     20 (76.92)                       23 (74.19)                   12 (100)
  NIT          10 μg              64 mm                                  28 (50.0)                32 (59.25)             30 (71.42)                     12 (46.15)                       ND                           4 (33.33)
  CFX          30 μg              24 mm                                  14 (25.0)                14 (25.0)              12 (28.57)                     8 (30.77)                        ND                           2 (16.67)
  VAN          30 μg              20 mm                                  12 (21.42)               ND                     ND                             ND                               6 (19.35)                    ND
  ERY          15 μg              20 mm                                  41 (73.21)               ND                     ND                             ND                               19 (61.29)                   ND

n

, total number of isolates tested; ND, not done; AMP, ampicillin; DOX, doxycycline; TCN, tetracycline; CIP, ciprofloxacin; IMP, imipenem; CHL, chloramphenicol; GEN, gentamycin; NAL, nalidixic acid; NIT, nitrofurantoin; CFX, cefoxitin; VAN, vancomycin; ERY, erythromycin.

The use of toxic metals in soluble forms as an alternative to prevent bovine CM appears to be a novel promising idea supported by several earlier studies ([@B58]; [@B68]). Zones of inhibition (ZOI) assays using the individual metal solution (Cu, Zn, Cr, Co, and Ni) demonstrated an increase in antimicrobial activity which correlated with an increased metal ion solution concentration (*P* \< 0.001) ([Figure 7](#F7){ref-type="fig"}). Thus, ZOI assays of metals demonstrated *S. aureus* (ZOI: 25.4 mm) as the most sensitive CM pathogens followed by *Bacillus* (ZOI: 23.4 mm), *E. coli* (ZOI: 20.6 mm), *Enterobacter* (ZOI: 18.9 mm), *Klebsiella* (ZOI: 17.8 mm), and *Shigella* (ZOI: 15.4 mm) ([Figure 7A](#F7){ref-type="fig"}). The minimal inhibitory concentration (MIC) of the metal ions demonstrated a varying degree of response against all the tested CM pathogens, and these bacteria tolerated a wide range of metal concentration (3.4--38.1 μg/mL) ([Supplementary Material](#FS1){ref-type="supplementary-material"}). We compared the highest MIC values of each metal, and found that the highest MIC values decrease in the following order: Zn (38.1 μg/mL, *S. aureus*), Cu (33.2 μg/mL, *S. aureus*), Ni (28.2 μg/mL, *E. coli*), Cr (17.2 μg/mL, *Enterobacter* species), and Co (15.3 μg/mL, *Bacillus* spp.) ([Figure 7B](#F7){ref-type="fig"} and [Supplementary Material](#FS1){ref-type="supplementary-material"}). For the MIC of specific bacteria, the most effective metals were found to be Cr against *Shigella* (3.4 μg/mL) and *Klebsiella* (5.8 μg/mL) species, Ni against *Shigella* (3.5 μg/mL) species, Co against *Shigella* (5 μg/mL) and *Klebsiella* (7.4 μg/mL) species, and Cu and Zn against *Shigella* (7.5 μg/mL, both) species. In contrast, Zn (38.1 μg/mL) and Cu (33.2 μg/mL) were the least toxic metals against *S. aureus* ([Figure 7B](#F7){ref-type="fig"} and [Supplementary Material](#FS1){ref-type="supplementary-material"}). A similar pattern was demonstrated for the minimal bactericidal concentration (MBC) with the greatest bactericidal activity for Cr against *S. aureus* (11.3 μg/mL) followed by Co against *E. coli* (14.3 μg/mL), Ni against *S. aureus* (23.1 μg/mL), Zn against *E. coli* (24.2 μg/mL), and Cu against *Shigella* (25.1 μg/mL) species. However, Cu produced equable antimicrobial efficacy as Zn, Cr, Co and Ni against *Enterobacter* species (≤25.5 μg/mL) ([Supplementary Table S2](#FS2){ref-type="supplementary-material"}).

![Antibacterial activity of heavy metals: Cu (CuSO~4~), Zn (ZnO), Cr (K~2~Cr~2~O~7~), Co (CoCl~2~) and Ni (NiCl~2~) against bovine CM pathogens. **(A)** Zone of inhibition (ZOI, mm) for six CM causing bacteria, each bar representing the mean values (values given horizontal axis of the bars, mm) and standard deviation error bar (SD error bar) for each bacterium. **(B)** Minimal inhibitory concentration (MIC) (expressed as μg/mL) of the tested metals against representative genera/species as determined by agar well diffusion method.](fmicb-11-00860-g007){#F7}

To assess the BF ability of CM pathogens in *in vitro* conditions, we randomly selected 80 isolates (*S. aureus*, 15; *E. coli*, 15; *Klebsiella*, 15; *Bacillus*, 15; *Enterobacter*, 10 and *Shigella*, 10) for a BF assay. In this study, 76.2% (61/80) the bacterial species were biofilm-formers with significance differences (*P* = 0.028) in their BF categories, which were designated as strong biofilm forming (SBF, 28.7%), moderate biofilm forming (MBF, 25.2%), weak biofilm forming (WBF, 22.2%), and non-biofilm forming (NBF, 23.7%) ([Figure 8](#F8){ref-type="fig"}). Microscopic observation followed by 3D image analysis revealed that the intensity of green fluorescence remained higher, indicating that a large number of cells were viable and attached to the surface ([Figure 8A](#F8){ref-type="fig"}). While investigated individually, *E. coli* (66.7%) remained as the highest biofilm producing CM pathogen followed by *Enterobacter* (60.0%), *Klebsiella* (46.7%), *S. aureus* (40.0%), *Shigella* (30.0%), and *Bacillus* (26.7%) species. Our current findings reveal that Gram-negative CM pathogens (*Enterobacter*, 60.0%; *E. coli*, 40.0%; *Shigella*, 33.3%; *Klebsiella*, 28.6%) have a higher biofilm producing ability than Gram-positive bacteria (*S. aureus*, 16.7%) ([Figures 8A,B](#F8){ref-type="fig"}). On the contrary, the majority of the *Bacillus* (73.3%), *Shigella* (70.0%), and *S. aureus* (60.0%) isolates remained as non-biofilm formers (NBF) ([Figure 8B](#F8){ref-type="fig"}). Therefore, our current findings of *in vitro* resistance analysis (antibiotics and metals resistance and biofilm assays) corroborate the resistome found in metagenome sequencing.

![Biofilm formation (BF) ability of the six CM causing pathogens. **(A)** Confocal fluorescence images (2D and 3D) of *S. aureus* (i,ii), *E. coli* (iii,iv), *Klebsiella* spp. (v,vi), *Enterobacter* spp. (vii,viii), *Bacillus* spp. (ix,x) and *Shigella* spp. (xi,xii). Scale bars are indicated in μm. **(B)** Capability of the biofilm formation by six CM causing bacteria.](fmicb-11-00860-g008){#F8}

Microbiome Functional Analysis {#S3.SS4}
------------------------------

We also investigated the possible links between chemotaxis and pathogenicity through the identification of putative genes or proteins associated with both flagellar motility and bacterial chemotaxis. The KEGG pathway analysis identified 48 protein families associated with flagellar motility in prokaryotes, and among them, flagellar hook-length control protein, FliK (27.1%); flagellar biosynthesis proteins, FlhA, FliL, FliP, FlhF, FlgN, FliS, FlhB, FliO, FliQ (∼16.0%); flagellar M-ring protein, FliF (5.6%); and flagellar regulatory protein, FleQ (5.3%) were predominantly associated with cell motility ([Supplementary Material](#FS1){ref-type="supplementary-material"}). Twenty-six functional genes encoding different proteins were found to be associated with bacterial chemotaxis ([Supplementary Figure S6](#FS3){ref-type="supplementary-material"} and [Supplementary Material](#FS1){ref-type="supplementary-material"}), of them, methyl-accepting chemotaxis protein, mcp (44.2%); chemotaxis family proteins of bacterial two component system, CheV, CheA, CheB, CheBR, CheY (∼15.0%); aerotaxis receptor, Aer (7.5%); MotB (5.2%), and MotA (3.1%) were the most abundant among these CM microbiotas ([Supplementary Material](#FS1){ref-type="supplementary-material"}). To explore the role of regulation and cell signaling mechanisms in mammary gland pathogenesis, using the SEED subsystem module of MR analysis, we found two-component regulatory systems BarA-UvrYBarA-UvrY (*sir*A) as the most abundant virulence regulatory gene (84.1%) in CM microbiomes ([Supplementary Material](#FS1){ref-type="supplementary-material"}). Another regulatory and cell signaling gene, endoplasmic reticulum chaperon *grp*78 (BiP), was also found as the single most abundant (93.8%) gene in the proteolytic pathways of the CM associated bacterial strains ([Supplementary Figure S7](#FS3){ref-type="supplementary-material"} and [Supplementary Material](#FS1){ref-type="supplementary-material"}). A deeper look at microbial genes associated with phages-prophages, transposable elements, and plasmids revealed that pathogenicity islands related proteins such as methionine-ABC transporter substrate-binding protein (33.8%), GMP synthase (27.7%), tmRNA-binding protein; SmpB (16.0%), heat shock protein 60; GroEL (16.0%), and SSU ribosomal protein; S18p (6.1%) were predominantly abundant among the CM pathogens ([Supplementary Material](#FS1){ref-type="supplementary-material"}). We also found significant associations between the number of reads assigned to genes coding for AMR and biofilm-formation-and-quorum-sensing (Pearson correlation, *P* = 0.0001), and in the relative abundance of genes coding for biofilm-formation and flagellar activities (Pearson correlation, *P* = 0.004). The SEED module analysis also enabled us to identify 28 different protein functions associated with oxidative stress responses that were mostly represented by catalase related proteins (26.7%), Cu-Zn-Fe-Mn mediated superoxide dismutase (12.7%), H~2~O~2~-inducible genes activator (7.8%), and paraquat-inducible protein B (7.3%) ([Figure 9](#F9){ref-type="fig"} and [Supplementary Material](#FS1){ref-type="supplementary-material"}).

![Projection of the clinical mastitis (CM) milk metagenome onto KEGG pathways. The whole metagenome sequencing (WMS) reveals significant differences (Kruskal--Wallis test, *P* = 0.001) in functional microbial pathways. A total of 28 genes associated with oxidative stress were found in CM microbiomes. Black lines with green circles delineate the distribution of the stress related genes according to their class across the CM metagenome. The diameter of the circles indicates the relative abundance of the respective genes. More details about these genes can be found in the text and [Supplementary Material](#FS1){ref-type="supplementary-material"}.](fmicb-11-00860-g009){#F9}

Discussion {#S4}
==========

Previously, we reported that the bovine CM milk microbiome harbors genes that may promote microbial pathogenicity, including AMR compared to the healthy state ([@B28]). In this study, we employed a combination of both *in silico* (WMS) and *in vitro* (culture-based) approaches to elucidate the resistance potentials in CM associated microbiomes. Currently, it is feasible to use metagenomic sequencing as a diagnostic tool for the detection of microbiome and its associated resistome in environmental samples ([@B55]; [@B60]; [@B38]). Shotgun metagenomics (WMS) investigations are progressively being used to analyze the ensemble of genes that may encode antibiotic resistance in various microbial ecosystems, which are defined as the resistome ([@B17]; [@B60]; [@B64]; [@B38]; [@B73]). The increasing prevalence of AMR in bacteria in bovine CM milk is one of the most important challenges that public health faces. It has been proposed that livestock production systems may contribute to an increased prevalence of antimicrobial resistant bacteria, and/or associated genes in the environment and therefore pose a risk to human health. Globally, more than 57 million kilograms of antibiotics are used annually in food animal production ([@B69]), which may select for antibiotic-resistant bacteria that persist throughout the meat and milk production chain. Investigation of the microbiome, and/or associated resistome of dairy animals especially in milk from cows with mastitis, and their environment may provide valuable data and models to estimate the public health risk of antibiotic-resistant human infections associated with antibiotic use in dairy animals ([@B72]).

Our present findings are sufficiently enriched in taxonomic resolution and predicted protein functions, and corroborates the findings of several previous studies ([@B50]; [@B16]; [@B52]; [@B28]). The occurrence of bovine mastitis could be affected by cattle breeds ([@B8]; [@B9]; [@B22]), and the diversity of CM-causing pathogens is associated with a broad range of host-defense mechanisms as part of its immunological arsenal ([@B65]; [@B41]). We found significant differences in taxonomic diversity and abundances among the CM microbiomes of four dairy breeds. The XHF cows suffering from CM had higher microbial diversity at strain-level, and a significant proportion of the microbiota found to be shared with that of the other three breeds (LZ, SW, and RCC). Consistent with the results of earlier studies ([@B8]; [@B9]; [@B22]; [@B41]), the taxonomic profile of the CM microbiomes found in four breeds of cows were dominated by phyla Proteobacteria, Bacteroidetes, Firmicutes, Actinobacteria, and Fusobacteria. This breed specific variation in taxonomic richness and diversity of the microbiome, especially in XHF and LZ cows, could be associated with their increased disease resistance or immune response ([@B8]; [@B9]; [@B22]), and rumen microbial features (e.g., taxa, diversity indices, functional categories, and genes) ([@B41]). However, this study demonstrated that the resistome is not significantly correlated with different dairy breeds suggesting that resistance potentials of CM microbiome might be common among dairy breeds. In our study, lack of congruence between resistome and microbial communities in four dairy breeds suggested that other factors, in addition to antimicrobial use, might be associated with changes in resistome, and microbiome composition. It may also reflect the possibility that a small fraction of the total bacterial population was resistant to antibiotics ([@B43]; [@B59]), and that horizontal gene transfer disrupted the link between microbiome and resistome composition ([@B31]). However, further investigations are necessary to evaluate the real effect of breed specific bacteria on cow mammary gland diseases. Recent understandings regarding evolutionary relationships of major CM causing bacteria are primarily based on 16S rRNA gene phylogenetic identification along with a few individual gene or protein sequences ([@B49]), which often produces conflicting phylogenies. This study explored the possibility that the prevalence of CM milk pathogens could vary according to geographical locations, and farming (semi-intensive to intensive grazing system in SER, semi-intensive to free-range grazing systems in CR) systems ([@B58]). These differences may imply that the etiology of bovine CM in Bangladesh could be related to the breed/host genetic factors ([@B8]; [@B9]; [@B22]; [@B41]), types of feeding, and farm locations and types ([@B58]), types of antibiotics and/or metals used for treatment resistomes, and other predisposing factors, as described in other countries ([@B56]; [@B58]; [@B5]).

Data presented here, coupled with the data reported in our earlier study ([@B28]) provide important insights into the resistance potentials in CM microbiomes. Our results are concordant with MDR bacteria reported elsewhere from the milk of clinically infected cows ([@B9]; [@B67]; [@B5]), buffalo cows ([@B56]), and humans ([@B54]; [@B52]; [@B3]). Our findings linked multidrug resistance to efflux pumps (MREP), *Cme*ABC operon, *mdt*ABCD cluster, *Bla*R1 family, methicillin resistance in *Staphylococcus* (MRS), resistance to fluoroquinolones (RFL), and multiple metals resistance to CZCR and AR as the predominantly abundant antibiotics and toxic compounds resistance (RATC) functional groups in CM microbiomes, suggesting that bovine CM milk microbiome constitutes a good reservoir for AMR ([@B36]; [@B54]; [@B3]; [@B28]). It has been reported that efflux pumps regulated by two-component systems in several pathogens, including *A. baumannii* and *K. pneumonia*, provide multidrug resistance, which may limit the treatment options against bacterial infections of the mammary glands ([@B42]; [@B66]). Relative over-expression of efflux pumps enhances resistance to antimicrobials by reducing the accumulation of antibiotics inside the bacterial cells, providing sufficient time for the bacteria to adapt to the antibiotics (slow phase antibiotic efflux), and through mutations or alteration of antibiotic targets ([@B71]; [@B66]). The *Cme*ABC operon is highly potent against multiple antibiotics, promotes the emergence of ARGs, and confers exceedingly high-level resistance to fluoroquinolones ([@B63]). Therefore, multidrug resistance to efflux pumps and multiple heavy metals resistance represented ubiquitous resistance mechanisms among CM microbiomes, which might be associated with unethical overuse of antibiotics in dairy animals ([@B56]; [@B9]; [@B67]; [@B5]; [@B72]), and extensive application of toxic chemicals and metals in agricultural use ([@B58]; [@B68]), or might have a function in the gut microbiome that is still unknown ([@B54]; [@B30]; [@B6]). The RATC genes detected in this study are of particular interest because there is concern that the use of this class of antibiotics or metals in veterinary medicine, particularly for food animals, may contribute to the development of resistance to this class of antimicrobial options in humans ([@B54]; [@B30]).

The *in vitro* antibiogram assays revealed that a high proportion of multidrug resistant (MDR) bacteria was frequently observed, where tetracyclines (tetracycline and doxycycline), quinolones (nalidixic acid), penicillins (ampicillin), and phenols (chloramphenicol) were the most common resistant antibiotics against the six selected CM pathogens. This finding of high MDR patterns for CM pathogens is in line with many previous studies on bovine mastitis ([@B56]; [@B5]). The AMR profile of bovine CM pathogens for different antimicrobials could vary according to the type and origin of bacteria ([@B56]; [@B69]; [@B5]) and host-population such as bovine ([@B67]; [@B5]) and bubaline ([@B56]) cows. Consistent with bacterial needs, heavy metals can be transformed (e.g., oxidized, reduced, methylated, or complexed) and used as a source of energy, terminal electron acceptors, and/or enzyme structural elements ([@B14]). The highest abundance of CZCR genes among CM pathogens is mainly due to the presence of Co, Zn, and Cd detoxification systems ([@B14]). Although understanding of the uncontrolled spread of ARGs in bovine mastitis pathogens ([@B5]) is growing, information on toxic compounds or heavy metal resistance remains unavailable. In this study, heavy metals (Cr, Co, Ni, and Cu) tested for antibacterial sensitivity showed good efficacy, but knowledge on their mode of action is limited. Thus, with the increase of MDR bacteria in CM, there is an imperative need for new biocidal and antimicrobial formulations. The MIC and MBC tested metals revealed effective antimicrobial efficacies against a wide range of AMR pathogens ([@B58]; [@B68]; [@B6]). We found that Cr and Co compounds had the highest antimicrobial efficacy (MIC) against all of the tested bacteria as supported by several previous studies ([@B68]; [@B48]). This finding is likely related to the better lipophilicity of Cr and Co, resulting in increased antimicrobial activities or chelating effects ([@B48]). However, both Cr and Co, should be used cautiously either in medication or in feed supplementation after calculating appropriate concentrations, to avoid cytotoxicity. These *in vitro* resistance patterns of CM bacteria corroborate the resistome profile of the WMS, since multidrug resistance to efflux pumps, resistance to fluoroquinolones, beta lactamases, and methicillin were the predominant antibiotics resistance functional groups, whereas cobalt, zinc, cadmium, copper, arsenic, and chromium resistance were the predominating toxic metals resistant genes in CM causing microbiomes. Molecular methods complemented with culture-based diagnostics have been historically implemented to document AMR in bacteria, however, the advent of shotgun metagenomics (WMS) has revolutionized the method of addressing relevant problems like diagnosis and surveillance of infectious diseases, and the issue of AMR ([@B12]). Biofilm formation is an important virulence factor that may result in recurrent or persistent udder infections ([@B47]), and treatment failure through increased resistance to antibiotics and protection against host defenses ([@B61]). The relative overexpression of genes encoding *lsr*ACDBFGE operon, biofilm adhesion biosynthesis, protein *Yjg*K cluster, and QS: autoinducer-2 synthesis in CM microbiomes is in accordance with several earlier reports ([@B21]; [@B61]; [@B28]). In this study, the relative abundance of the predicted proteins for BF and QS varied significantly among the six selected bacterial taxa. Bacterial BF and QS abilities can be the strain specific or genetically linked traits, representing a selective advantage in pathogenesis of bovine CM ([@B61]). Biofilms can enhance proliferation of reactive oxygen and nitrogen species that can survive antibiotic treatment leading to the transfer of ARGs ([@B21]). In this study, overall, 76.2% of the isolates of the six selected CM pathogens were found as biofilm producers, and their ability to produce biofilm varied significantly ([@B21]; [@B61]). A large number of food spoilage and/or pathogenic bacteria, including *Enterococcus faecalis*, *Enterobacter* spp., *Pseudomonas* spp., *Klebsiella* spp., *S. aureus*, *E. coli*, *B. cereus*, and others, have already been reported to be associated with biofilm-formation (BF) from diary niches ([@B47]; [@B21]; [@B61]; [@B63]; [@B68]) which supports our current findings.

Bacterial chemotaxis mediated by flagellar activities ([@B15]) and the flagella mediated virulence factors are found in many pathogenic species of bovine CM microbiomes, making them a potential target for new antibacterial therapeutics ([@B15]). The intra- and interspecies cell-to-cell communication in bovine CM microbiomes were associated with 26 different genes, which might have vital roles in the early phase of mastitis for attachment to, or entry into the udder tissues and virulence regulation ([@B74]), and bacterial colonization in mammary tissues like other suitable sites ([@B45]). The *cheA-cheY* two-component system mediated bacterial chemotaxis also facilitates the initial contact of bacteria with mammary gland epithelial cells, and contribute to effective invasion ([@B13]). The two-component signal transduction system *BarA-UvrY* regulates metabolism, motility, BF, stress resistance, virulence, and QS in CM pathogens by activating the transcription of genes for regulatory small RNAs ([@B75]). The up-regulation of genes coding for proteolytic activity, *grp78* during host-pathogen interactions in CM, is associated with endoplasmic reticulum (ER) stress which further triggers proteolytic activities to initiate the mechanism of pathogenesis and cell death ([@B24]). Catalase activity is a marker of bovine mastitis, which plays a central role in milk redox control and markedly increases during the pathophysiology of bovine CM ([@B2]). Our present findings are in line with previous reports ([@B2]; [@B10]) that an elevated oxidative stress mediated by catalase activity might have originated either from the mammary gland and/or bacterial cells. During the pathogenesis of bovine mammary gland, bacteria are not rapidly killed by the phagocytic activity of bovine macrophages; rather, they survive within macrophages during prolonged infection due to secretion of catalase and superoxide dismutase, which by degrading H~2~O~2~, inhibit the ROS mediated killing mechanism of the host ([@B2]; [@B10]). The majority of published studies on bovine mastitis describe 16S rRNA gene-based community structure evaluations, whereas published reports on shotgun deep sequencing metagenomics of CM microbiome studies remain scarce. We completed an in-depth report simultaneously describing microbiome diversity along with previously unreported opportunistic strains, and their associated resistome in bovine mastitis.

Conclusion {#S5}
==========

Bovine CM milk is a potential reservoir of diverse groups of microbes harboring a diverse resistome and other virulence factors. Our findings reveal that genes coding for multidrug and multiple metal resistance are ubiquitously present in the CM microbiome, and protect bacteria from the antibacterial effects of antimicrobials, extruding them out of cells. The efflux pumps mediated by multidrug resistance and multiple metals (e.g., cobalt, zinc, cadmium, arsenic, chromium) resistance were the predominating genomic functional groups to be considered as the potential key factors for the persistence of bovine CM, and the failure of conventional therapies against CM-related pathogens. Additionally, BF, QS, bacterial flagellar movement and chemotaxis, regulation and cell signaling, and oxidative stress associated genes can be a great benefit to bacteria against the host's immune system. Microbial resistance and genomic functional potentials represent important mechanisms for antibiotic resistance, leading to treatment failure and persistence of the disease. An accurate and timely identification of CM-associated pathogens and analyses of their resistance potentials are necessary for the selection of proper therapeutics (antibiotics and/or metals), and the development of effective, safe, and economical treatment regimens for bovine mastitis and sustainable dairying. Although the baseline data presented here are promising, further studies are recommended using a larger sample size, and with the inclusion of gut microbiome sampling in addition to the milk samples to elucidate the specific resistance potential of CM pathogens as well as for direct testing of microbiome and resistome transfer across this axis.
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